Immunological reconstitution after autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia.: Comparison with an historical non-Hodgkin's lymphoma group

被引：0
|
作者：
Laurenti, L [1 ]
Piccirillo, N [1 ]
Sorà, F [1 ]
Piccioni, P [1 ]
Tarnani, M [1 ]
Leone, G [1 ]
Sica, S [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Div Ematol, Rome, Italy
来源：
HAEMATOLOGICA | 2004年 / 89卷 / 01期
关键词：
immune recovery; hematologic reconstitution; chronic lymphocytic leukemia;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The kinetics of immune reconstitution after autologous peripheral blood stem cell transplantation (APBSCT) was examined in a group of 6 patients with chronic lymphocytic leukemia (CLL) and compared to that in an historical group of 12 patients with non-Hodgkin's lymphoma (NHL). Lymphocyte analysis included total lymphocyte count, CD3, CD4, CD8, CD4/8 ratio, CD19, and CD16/56 counts before, on day +15, +30, +60, +90, and +120 and 1 year after transplantation. Immunological recovery in the CLL group was similar to that in the NHL group.
引用
收藏
页码：120 / 122
页数：3
相关论文
共 45 条
  • [31] Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma
    Tachi, T.
    Yasuda, M.
    Usui, K.
    Umeda, M.
    Nagaya, K.
    Osawa, T.
    Ichihashi, A.
    Noguchi, Y.
    Goto, H.
    Kasahara, S.
    Takahashi, T.
    Garo, C.
    Teramachi, H.
    PHARMAZIE, 2015, 70 (10): : 674 - 677
  • [32] Positive selection and transplantation of autologous highly purified CD133+ stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging
    Isidori, Alessandro
    Motta, Maria Rosa
    Tani, Monica
    Terragna, Carolina
    Zinzani, Pierluigi
    Curti, Antonio
    Rizzi, Simonetta
    Taioli, Simona
    Giudice, Valeria
    D'Addio, Alessandra
    Gugliotta, Gabriele
    Conte, Roberto
    Baccarani, Michele
    Lemoli, Roberto M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) : 1224 - 1232
  • [33] Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in group of 149 patients
    Laurenti, L
    Piccioni, P
    Piccirillo, N
    Sora', F
    Chiusolo, P
    Garzia, M
    Reddiconto, G
    De Matteis, S
    Tarnani, M
    Leone, G
    Sica, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 2063 - 2070
  • [34] Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia
    Hebenstreit, Karin
    Iacobelli, Simona
    Leiblein, Sabine
    Eisfeld, Ann-Kathrin
    Pfrepper, Christian
    Heyn, Simone
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Krahl, Rainer
    Fricke, Stephan
    Becker, Cornelia
    Poenisch, Wolfram
    Behre, Gerhard
    Niederwieser, Dietger
    Lange, Thoralf
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1274 - 1280
  • [35] Flow cytometry immunophenotyping of peripheral blood circulating B-cell subset: comparison of osteoarthritis, chronic lymphocytic leukemia patients and normal donors
    Artjoms Spaks
    Irina Spaka
    Alla Rivkina
    Journal of Translational Medicine, 9 (Suppl 2)
  • [36] Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)
    Arpaci, F
    Dogru, T
    Ozturk, B
    Komurcu, S
    Ozet, A
    Yilmaz, MI
    Beyzadeoglu, M
    Turan, A
    Sengul, A
    Yalcin, A
    HAEMATOLOGIA, 2002, 32 (03) : 253 - 264
  • [37] Phase II Study of Interleukin-4 in Indolent B-cell Non-Hodgkin Lymphoma and B-cell Chronic Lymphocytic Leukemia: A Study of the Eastern Cooperative Oncology Group (E5Y92)
    Wiernik, Peter H.
    Dutcher, Janice P.
    Yao, Xiapan
    Venkatraj, Usha
    Falkson, Carla I.
    Rowe, Jacob M.
    Cassileth, Peter A.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (09) : 1006 - 1009
  • [38] An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT
    Kouroukis, C. T.
    Crump, M.
    MacDonald, D.
    Larouche, J. F.
    Stewart, D. A.
    Johnston, J.
    Sauvageau, S.
    Beausoleil, E.
    Sage, P.
    Dubois, S. G.
    Christofides, A.
    Di Clemente, S.
    Sehn, L.
    CURRENT ONCOLOGY, 2015, 22 (04) : 260 - 271
  • [39] Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: Comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia
    Finn, WG
    Singleton, TP
    Schnitzer, B
    Ross, CW
    Stoolman, LM
    HUMAN PATHOLOGY, 2001, 32 (01) : 66 - 73
  • [40] Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-α-2a treatment
    Beksaç, M
    Arat, M
    Akan, H
    Koç, H
    Ilhan, O
    Özcan, M
    CANCER, 2000, 89 (07) : 1474 - 1481
12345